LIWANLI Innovation Co., Ltd.
3054
Rank in Stocks
#18204
LIWANLI Innovation Co., Ltd. operates within the biomedical science sector,... LIWANLI Innovation Co., Ltd. operates within the biomedical science sector, concentrating on the development and distribution of nutrition and healthcare solutions. The company's diverse product portfolio, which notably features the Vigoway line and various powdered formulations, is designed to serve a wide range of consumers, including men, women, seniors, and children. Its extensive offerings encompass products such as probiotic enzymes, active nutrients, resveratrol red grape extract, and a variety of soft gels (including those with algae DHA, shea butter with type II collagen, and algae astaxanthin Q10). Other specialized items include cordyceps militaris powder, tooth guard tablets, bovine and goat's milk bites, bilberry tablets, and DHA and vitamin D3 drops, among others. The firm was formerly known as Carry Technology International Co., Ltd. before officially adopting its current name, LIWANLI Innovation Co., Ltd., in 2015. Established in 1980, the company's headquarters are located in New Taipei City, Taiwan.
Share Price
$1.75
Last synced: 2026-11-10
Market Cap
$141.12M
Change (1 day)
2.87%
Change (1 year)
136.45%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade LIWANLI Innovation Co., Ltd. (3054)
Category
Healthcare
Operating Margin for LIWANLI Innovation Co., Ltd. (3054)
Operating Margin as of November 2026 TTM: 32.48%
According to LIWANLI Innovation Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 32.48%. At the end of 2025 the company had an operating margin of -56.42%.
Operating Margin history for LIWANLI Innovation Co., Ltd. from 2009 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 32.48% | -157.57% |
| 2025 | -56.42% | 48.05% |
| 2024 | -38.11% | 0.00% |
| 2023 | 0.00% | -100.00% |
| 2022 | -352.89% | -392.15% |
| 2021 | 120.79% | -2,140.37% |
| 2020 | -5.92% | -156.70% |
| 2019 | 10.44% | -134.49% |
| 2018 | -30.27% | -17.90% |
| 2017 | -36.87% | 443.81% |
| 2016 | -6.78% | -46.49% |
| 2015 | -12.67% | 1,233.68% |
| 2014 | -0.95% | -110.24% |
| 2013 | 9.28% | -455.56% |
| 2012 | -2.61% | 443.75% |
| 2011 | -0.48% | -87.03% |
| 2010 | -3.70% | -166.31% |
| 2009 | 5.58% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -99.40% |
DE
|
|
| 19.68% | -99.39% |
DE
|
|
| 13.26% | -99.59% |
JP
|
|
| 17.08% | -99.47% |
CH
|
|
| 14.92% | -99.54% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about LIWANLI Innovation Co., Ltd.'s operating margin
What is LIWANLI Innovation Co., Ltd.'s operating margin?
LIWANLI Innovation Co., Ltd.'s operating margin is 32.48%, as of Nov 2026.
What was LIWANLI Innovation Co., Ltd.'s operating margin in 2025?
In 2025, LIWANLI Innovation Co., Ltd.'s operating margin was -56.42%, compared with -38.11% in 2024.
How has LIWANLI Innovation Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, LIWANLI Innovation Co., Ltd.'s operating margin was highest in 2021 (120.79%) and lowest in 2022 (-352.89%).
How does LIWANLI Innovation Co., Ltd.'s operating margin compare with similar companies?
LIWANLI Innovation Co., Ltd.'s operating margin (32.48%) is higher than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.